Lawinski v. Saiki — Clarifies Auto Insurance Coverage Rule for Medical Treatments

Case
In the Matter of the Request for Payment of, CHRISTOPHER LAWINSKI, M.D., as Provider for Sean Tilton, v. SCOTT SAIKI, INSURANCE COMMISSIONER, DEPARTMENT OF COMMERCE AND CONSUMER AFFAIRS, STATE OF HAWAIʻI, and UNITED SERVICES AUTOMOBILE ASSOCIATION
Court
Supreme Court of the State of Hawaiʻi
Judge
EDDINS, J. (appointment info not available)
Date Decided
July 29, 2026
Docket No.
SCWC-23-0000289
Topics
Insurance Law, No-Fault Insurance, PIP Benefits, Statutory Interpretation
Source
Read the full opinion

Background

After Sean Tilton was injured in a car crash, his physician, Dr. Christopher Lawinski, treated him with low-level laser therapy (LLLT). Dr. Lawinski billed Tilton’s no-fault auto insurer, United Services Automobile Association (USAA), for the treatments under Tilton’s personal injury protection (PIP) plan. USAA contested the claim and paid only a fraction of the billed amount, asserting that LLLT was not a covered benefit under the governing state law.

Dr. Lawinski challenged the denial. The case proceeded through an administrative hearing process where the Insurance Commissioner sided with USAA. The Commissioner found that while the treatment may have been necessary, Dr. Lawinski failed to provide any evidence that LLLT is a treatment “substantially comparable to the requirements for prepaid health care plans,” a necessary condition for coverage under Hawaiʻi Revised Statutes (HRS) § 431:10C-103.5(a). The case was appealed through the state court system, with the circuit court affirming the Commissioner’s decision. The Intermediate Court of Appeals (ICA) also affirmed but did so on the grounds that the statute was ambiguous.

The Court’s Holding

The Supreme Court of Hawaiʻi affirmed the judgment of the lower courts, agreeing that USAA was not required to pay for the LLLT treatment. However, the court corrected the ICA’s reasoning, holding that the controlling statute, HRS § 431:10C-103.5(a), is unambiguous. The court explained that the statute plainly sets forth two distinct conditions for a treatment to be a covered PIP benefit: it must be (1) “appropriate and reasonable” and “necessarily incurred,” and (2) “substantially comparable to the requirements for prepaid health care plans.”

The court found that Dr. Lawinski had failed to meet his burden of proof on the second condition. During the administrative hearing, Dr. Lawinski’s expert witness admitted he had “no idea” if any prepaid health plan in Hawaiʻi covered LLLT, and Dr. Lawinski himself conceded he had never billed such a plan for the treatment. Because the provider offered no evidence to satisfy the comparability requirement, the treatment was not a compensable PIP benefit. The court dismissed Dr. Lawinski’s argument that legislative history supported a “generous” interpretation, noting that where a statute’s text is clear, its plain meaning controls.

Key Takeaways

  • In Hawaiʻi, a medical treatment under an auto insurance PIP plan must satisfy two conditions: it must be appropriate and necessary, AND it must be substantially comparable to what prepaid health care plans cover.
  • The burden falls on the medical provider to prove that a treatment meets both statutory conditions for coverage. A failure to provide evidence on either condition is fatal to a claim for payment.
  • A statutory phrase is not legally ambiguous if the legislature has provided a definition for it, even if that definition is in a separate section. Courts must apply the statutory definition as written.

Why It Matters

This decision provides a clear directive to medical providers and auto insurers in Hawaiʻi, reinforcing the strict, two-part test for PIP benefit eligibility. It clarifies that demonstrating a treatment’s medical necessity is not enough; providers must also be prepared to prove that the treatment is comparable to those covered by mainstream prepaid health plans. The ruling serves to contain auto insurance costs by tethering PIP benefits to established healthcare standards, preventing the expansion of coverage to include novel or alternative therapies that are not widely accepted by major health plans. It also underscores a principle of statutory interpretation: when the legislature defines its own terms, courts will not look to legislative history to create ambiguity where none exists.

✉️ Get tomorrow’s cases before your first coffee
Daily Case Law is our free morning digest — the most substantive new decisions, filtered to your jurisdictions and topics, each linking back here for the full analysis.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top